The United Laboratories International Holdings Limited

中/EN
中文繁體 English
  • Investor Relations
    IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
  • Corporate
Investor Relations
  • IR Home
  • Corporate Overview
  • Financial Highlights
  • Financial Reports
  • ESG Reports
  • Regulatory Filings
    1. Announcements & Notices
    2. Circulars
    3. Returns on Share Capital
    4. Listing Documents
    5. Constitutional Documents
  • Press Releases
  • Company
    Presentations
  • Stock Quotes &
    Charts
  • Analyst Coverage
  • FAQs
  • IR Contact

Announcements & Notices

2022
Please select
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
MAY
05
LOAN FACILITY WITH INDUSTRIAL BANK HONG KONG BRANCH - ANNOUNCEMENT PURSUANT TO RULE 13.18 OF THE LISTING RULES
APR
28
NOTICE OF ANNUAL GENERAL MEETING
APR
26
UPDATED INFORMATION OF THE GROUP'S PRODUCTS - INSULIN DEGLUDEC AND INSULIN ASPART INJECTION
APR
26
UPDATED INFORMATION OF THE GROUP'S PRODUCTS - BIAPENEM FOR INJECTION
MAR
24
Special dividend for the year ended 31 December 2021
MAR
24
Final dividend for the year ended 31 December 2021
MAR
24
2021 ANNUAL RESULTS ANNOUNCEMENT
MAR
15
POSITIVE PROFIT ALERT
MAR
11
DATE OF BOARD MEETING
JAN
03
VOLUNTARY ANNOUNCEMENT PROPOSED FURTHER SHARE BUY-BACK UNDER GENERAL MANDATE
Disclaimer | Sitemap

Copyright © 2019 The United Laboratories International Holdings Limited. All rights reserved.